RNAC
Price:
$6.9
Market Cap:
$179.42M
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in Phase I clinical trial to enhance the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therap...[Read more]
Industry
Biotechnology
IPO Date
2016-06-22
Stock Exchange
NASDAQ
Ticker
RNAC
According to Cartesian Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Cartesian Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), RNAC's Dividend Yield was at its highest in in the December 2015 quarter at 0%. The Dividend Yield was at its lowest in in the December 2015 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Cartesian Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
| 2015 | 0% | 0% |
The current Dividend Yield of Cartesian Therapeutics, Inc. (RNAC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Cartesian Therapeutics, Inc.’s Dividend Yield is less than Eupraxia Pharmaceuticals Inc. (0%), less than Inventiva S.A. (0%), less than Nautilus Biotechnology, Inc. (0%), less than Orchestra BioMed Holdings, Inc. (0%), less than MediWound Ltd. (0%), less than Aardvark Therapeutics, Inc. Common Stock (0%), less than Fennec Pharmaceuticals Inc. (0%), less than Avalo Therapeutics, Inc. (0%), less than NEONC TECHNOLOGIES HOLDINGS, INC. (0%), less than Genfit S.A. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $196.53M | |
| 0% | $217.29M | |
| 0% | $261.45M | |
| 0% | $264.25M | |
| 0% | $195.31M | |
| 0% | $269.99M | |
| 0% | $214.34M | |
| 0% | $202.73M | |
| 0% | $182.08M | |
| 0% | $290.81M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cartesian Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cartesian Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Cartesian Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Cartesian Therapeutics, Inc. (RNAC)?
What is the highest Dividend Yield for Cartesian Therapeutics, Inc. (RNAC)?
What is the 3-year average Dividend Yield for Cartesian Therapeutics, Inc. (RNAC)?
What is the 5-year average Dividend Yield for Cartesian Therapeutics, Inc. (RNAC)?
How does the current Dividend Yield for Cartesian Therapeutics, Inc. (RNAC) compare to its historical average?